Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#94 most reported symptom for this vaccine
Upper respiratory tract infection has been reported 179 times in association with Pneumococcal (Prevnar) vaccination in VAERS. This represents 0.6% of all 27,970 reports for this vaccine.
Among these reports, 24 mentioned death (13.41%) and 58 involved hospitalization (32.4%).
Upper respiratory tract infection is the #94 most frequently reported symptom for Pneumococcal (Prevnar) out of 1407 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 179 reports of Upper respiratory tract infection after Pneumococcal (Prevnar) vaccination may seem alarming, but context is critical.
The 13.41% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.